Related Experiment Videos

Modulation of peripheral blood mononuclear cell activation status during Salmonella-triggered reactive arthritis

J Kirveskari1, Q He, T Holmström

  • 1National Public Health Institute, Turku, Finland.

Arthritis and Rheumatism
|October 19, 1999
PubMed
Abstract

Insights

Peripheral blood mononuclear cells (PBMC) show activation during Salmonella-triggered reactive arthritis (ReA). Monocyte activation decreases during recovery, with CD14 down-regulation specific to ReA patients, suggesting suppressed PBMC activity aids recovery.

Area of Science:

  • Immunology
  • Rheumatology
  • Infectious Diseases

Background:

  • Reactive arthritis (ReA) can be triggered by Salmonella infections.
  • Understanding the immune cell activation status in ReA is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the activation status of peripheral blood mononuclear cells (PBMC) during the acute and recovery phases of Salmonella-induced ReA.

Main Methods:

  • Studied PBMC from 8 patients (4 with ReA, 4 without) with Salmonella infection.
  • Utilized reverse transcription-polymerase chain reaction (RT-PCR) for cytokine mRNA.
  • Employed flow cytometry (FC) for cell surface markers and immunofluorescence (IF) for bacterial antigens.

Main Results:

  • PBMC activation, indicated by CD14, CD11b, and CD11c expression, was observed in all patients during acute infection.
  • ReA patients showed higher production of proinflammatory cytokines (IL-1beta, IL-6, IL-8, TNF-alpha) and IL-10.
  • Monocyte activation decreased during disease amelioration, with complete CD14 down-regulation unique to ReA patients.

Conclusions:

  • Activated PBMC, particularly monocytes expressing specific markers and cytokines, are characteristic of acute Salmonella-triggered ReA.
  • Down-regulation of CD14 and reduced cytokine production during disease improvement suggest suppressed PBMC activity is involved in ReA recovery.

Related Concept Videos